Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for hemostasis after tibial osteotomy
IRCT20190325043107N25Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in Bleeding (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Bleeding. Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20190325043107N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N25.